COMMUNIQUÉS West-GlobeNewswire

Centralis Health Joins DirectTrust To Help Drive Health Information Exchange

30/10/2024 - 14:15

Through membership, Centralis Health will play an important role in informing standards and policy development for critical health information transmission TALLAHASSEE, Fla., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Centralis [...]

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

30/10/2024 - 14:15

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced today that it has regained [...]

Alira Health publie un rapport mondial sur les tendances et les dynamiques concurrentielles du marché des biosimilaires

30/10/2024 - 14:14

L’analyse projette une croissance annuelle de 19 %, avec des ventes mondiales qui devraient dépasser 64 milliards de dollars d’ici à 2028. FRAMINGHAM, Massachusetts, 30 oct. 2024 (GLOBE NEWSWIRE) -- Alira Health, une [...]

IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting

30/10/2024 - 14:05

Results from OVATION 2 Study of IMNN-001 to be highlighted in late-breaking acceptance Company also announces FDA End-of-Phase 2 in-person meeting to discuss Phase 3 trial of IMNN-001 Phase 3 trial is expected to begin [...]

Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

30/10/2024 - 14:01

WALTHAM, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]

H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards

30/10/2024 - 14:00

Users now have access to patient diversity insights across major clinical trial markets representing more than 500 million patients NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- H1 , on a mission to connect the world to [...]

Digital Utilities Ventures Expands Dealer Network and Reports Strong Q1 Results, Setting the Stage for Continued Growth

30/10/2024 - 14:00

MANKATO, Minn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Digital Utilities Ventures (OTC: DUTV) is pleased to announce the significant expansion of its sales force for its innovative modular Easy Nano Void Water Clean Up and [...]

Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed

30/10/2024 - 14:00

Boston IVF to begin providing FemaSeed as an infertility treatment option to expand access for patients across nearly 30 centers nationwide ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a [...]

VIVUS and UpScriptHealth Announce Launch of ChooseQ.online for Access to Advanced Weight Management Solutions

30/10/2024 - 14:00

Collaborative telehealth platform will provide patients with immediate access to QSYMIA ® , a chronic weight loss medication, enhancing their healthcare journey CAMPBELL, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- VIVUS [...]

CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies with SMC Laboratories

30/10/2024 - 13:30

VANCOUVER, Wash., Oct. 30, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic [...]

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

30/10/2024 - 13:30

WOBURN, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a [...]

Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success

30/10/2024 - 13:30

CAMBRIDGE, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) today announced the successful completion of a comprehensive financial restructuring of the Company [...]

Vireo Growth Inc. to Release Third Quarter 2024 Results on November 13, 2024

30/10/2024 - 13:30

MINNEAPOLIS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (formerly Goodness Growth Holdings, Inc.) ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), a cannabis company committed to providing safe access, [...]

Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

30/10/2024 - 13:30

Access the Virtual Investor “What This Means” Segment here THE WOODLANDS, TX, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on [...]

Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update

30/10/2024 - 13:30

Conference Call and Webcast Scheduled for November 7, 2024 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage [...]

Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study

30/10/2024 - 13:30

NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]

Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET

30/10/2024 - 13:30

REYKJAVIK, Iceland, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release [...]

Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET

30/10/2024 - 13:30

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release financial results for first nine months of the year ended [...]

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

30/10/2024 - 13:19

Patients experiencing bloating and gastrointestinal discomfort can now order inFoods ® IBS directly from www.infoodsIBS.com without needing to visit a doctor’s office With a simple, at-home finger-prick blood sample, [...]